somatorelin | CAS:83930-13-6

We serve somatorelin CAS:83930-13-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
somatorelin

Chemical Name:somatorelin
CAS.NO:83930-13-6
Synonyms:somatorelin
Human growth hormone-releasing hormone (1-44) amide
Growth-hormone-releasing hormone
GRF (1-44) (human)
Somatoliberin (human)
 
Physical and Chemical Properties:
Molecular Formula C215H358N72O66S
Molecular Weight 5039.65
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Growth hormone releasing factor (GRF) is a hypothalamic hormone which regulates the synthesis and secretion of growth hormone from the anterior pituitary.



Contact us for information like somatorelin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Somatoliberin (human) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Growth-hormone-releasing hormone Use and application,Somatoliberin (human) technical grade,usp/ep/jp grade.


Related News: China is now dealing with another disease outbreak — this one mostly affecting animals but also potentially deadly among people.4-N-PENTYLOXYBENZALDEHYDE manufacturer China is now dealing with another disease outbreak — this one mostly affecting animals but also potentially deadly among people.Hydroquinone supplier He added that the government raised the travel advice warning to level four, the highest, meaning they’re now advising people not to travel to mainland China. The warning aims to address “the issue of the human-to-human transmission of the coronavirus.”5-Bromo-2-Hydroxy-3-Picoline vendor He added that the government raised the travel advice warning to level four, the highest, meaning they’re now advising people not to travel to mainland China. The warning aims to address “the issue of the human-to-human transmission of the coronavirus.”China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.